|
(V1487) |
The Eph/ephrin-A system as determinant for proliferation in vascular smooth muscle cells – Implications for arteriosclerosis development? |
| |
|
A. Augstein, S. Jellinghaus, G. Ende, A. Männel, V. Adams, A. Linke, D. M. Poitz (Dresden) |
|
|
Diskussion |
|
(V1488) |
Glucose lowering accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice |
| |
|
J. Pennig, N. Anto Michel, P. Scherrer, M. C. Gißler, N. Hoppe, L. Füner, P. Stachon, D. Wolf, C. Härdtner, I. Hilgendorf, A. Zirlik, F. Willecke (Freiburg im Breisgau; Singapur, SG; Graz, AT) |
|
|
Diskussion |
|
(V1489) |
Improved collateral growth by the toll-like receptor 2/6 ligand MALP-2 |
| |
|
A.-K. Vlacil, K. Troidl, C. Schubert, R. Chennupati, J. Schütt, R. Oberoi, T. Schmitz-Rixen, B. Schieffer, K. Grote (Marburg, Bad Nauheim, Frankfurt am Main) |
|
|
Diskussion |
|
(V1490) |
The RNA-binding protein hnRNPU reduces miRNA packaging into EVs through direct binding, stabilization and transcription inhibition |
| |
|
A. Zietzer, M. R. Hosen, G. Nickenig, N. Werner, F. Jansen (Bonn) |
|
|
Diskussion |
|
(V1491) |
Pro-apoptotic C16 Ceramide is enriched in extracellular vesicles and influences the phenotype of vesicle recipient cells |
| |
|
A. Zietzer, L. Jahnel, M. R. Hosen, K. Gutbrod, P. Dörmann, G. Nickenig, N. Werner, F. Jansen (Bonn) |
|
|
Diskussion |
|
(V1492) |
Cardiovascular benefits of GLP-1 (Liraglutide) treatment in experimental arterial hypertension are mediated by the endothelial GLP-1 receptor |
| |
|
S. Steven, J. Helmstädter, K. Filippou, F. Pawelke, K. Frenis, K. Vujacic-Mirski, S. Kalinovic, S. Kröller-Schön, M. Oelze, T. Münzel, A. Daiber (Mainz) |
|
|
Diskussion |
|
(V1493) |
The SGLT2 inhibitor Empagliflozin accelerates endothelial regeneration and prevents neointima formation |
| |
|
L. M. Bode, J. Dutzmann, L. Korte, J. Bauersachs, D. G. Sedding (Hannover, Halle) |
|
|
Diskussion |
|
(V1494) |
The role of CRIP1 in immunological mechanisms in hypertension |
| |
|
O. Schweigert, D. Aissi, C. Müller, J. Straubinger, N. Längst, D.-A. Tregouet, T. Zeller, S. Blankenberg, für die Studiengruppe: Cardiogenics (Hamburg, Tübingen; Bordeaux, FR) |
|
|
Diskussion |
|
(V1495) |
Periinterventional cocoa flavanol supplementation prevents functional and structural damage to the arterial wall after transradial catheterintervention |
| |
|
M. Gröne, M. Ophoff, C. Heiss, M. Kelm, R. Sansone (Düsseldorf; Guildford, Surrey, UK) |
|
|
Diskussion |